Why the study?
Does treatment with dantrolene and bromocriptine improve symptoms of neuroleptic malignant syndrome?
Does treatment with dantrolene and bromocriptine improve symptoms of neuroleptic malignant syndrome?
Parenteral dantrolene and high-dose bromocriptine can successfully treat the hyperthermia, rigidity, and other symptoms of neuroleptic malignant syndrome.
Answers are grounded in this paper and cite their sources.
May support dantrolene and bromocriptine for neuroleptic malignant syndrome symptoms; hypothesis-generating pending controlled trials.
A patient with chronic schizophrenia treated with fluphenazine developed neuroleptic malignant syndrome, characterized by fever, obtundation, rigidity, and tremulousness. Hyperthermia and elevated serum creatine kinase were successfully corrected by parenteral treatment with dantrolene. Obtundation, rigidity, and tremulousness responded to high doses of bromocriptine.
No takes yet. Share an insight, caveat, or question.
Granato et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: